A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by Cardiopulmonary Exercise Testing in Subjects with World Health Organization Group 1 Pulmonary Hypertension Who Recently Initiated Therapy

  • Brown, Martin (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Rai, Meenal (Clinical Trial Unit Staff)
  • Parshionikar, Abhijit (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleROR-PH-302
AcronymADVANCE capacity
Effective start/end date1/07/2031/03/25